These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 6379511

  • 1. Clinical effect of interferon in malignant brain tumours.
    Nagai M, Arai T.
    Neurosurg Rev; 1984; 7(1):55-64. PubMed ID: 6379511
    [Abstract] [Full Text] [Related]

  • 2. [Current status of interferon therapy on malignant brain tumor].
    Nagai M, Arai T, Kohno S, Iizuka E.
    Gan No Rinsho; 1983 May; 29(6):608-15. PubMed ID: 6876429
    [Abstract] [Full Text] [Related]

  • 3. [Current status and problems of cancer treatment with interferon].
    Ichikawa H.
    Gan No Rinsho; 1983 May; 29(6):616-9. PubMed ID: 6876430
    [Abstract] [Full Text] [Related]

  • 4. [Effect of human fibroblast interferon on malignant brain tumors].
    Nakamura O, Teramoto A, Yamamoto H, Ochiai C, Takakura K, Maruo K, Ueyama Y, Shimamura K.
    No To Shinkei; 1983 Sep; 35(9):905-11. PubMed ID: 6651989
    [Abstract] [Full Text] [Related]

  • 5. [Clinical effect of human fibroblast interferon (BM532) on malignant brain tumors--with special reference to gliomas].
    Nagai M.
    Nihon Gan Chiryo Gakkai Shi; 1989 Mar 20; 24(3):638-46. PubMed ID: 2671205
    [Abstract] [Full Text] [Related]

  • 6. Effect of human leukocyte interferon on malignant brain tumors.
    Hirakawa K, Ueda S, Nakagawa Y, Suzuki K, Fukuma S, Kita M, Imanishi J, Kishida T.
    Cancer; 1983 Jun 01; 51(11):1976-81. PubMed ID: 6839290
    [Abstract] [Full Text] [Related]

  • 7. [Efficacy of interferon-beta and interleukin-2 as cytokines for malignant brain tumor treatment].
    Shitara N, Nakamura H, Genka S, Takakura K.
    Gan To Kagaku Ryoho; 1987 Dec 01; 14(12):3235-44. PubMed ID: 3318704
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of recombinant leukocyte A interferon (Ro 22-8181) in malignant brain tumors].
    Gan To Kagaku Ryoho; 1985 Apr 01; 12(4):913-20. PubMed ID: 3885862
    [Abstract] [Full Text] [Related]

  • 9. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.
    Merchant RE, McVicar DW, Merchant LH, Young HF.
    J Neurooncol; 1992 Jan 01; 12(1):75-83. PubMed ID: 1541981
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of recombinant interferon-alpha 2 following intralesional administration in malignant glioma patients.
    Maleci A, Antonelli G, Guidetti B, Dianzani F.
    J Interferon Res; 1987 Feb 01; 7(1):107-9. PubMed ID: 3585078
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy and adverse effects of beta-interferon in the treatment of malignant glioma].
    Oda Y, Konishi T, Suzui H, Kamijo Y, Kang Y, Okumura T, Kaneko T, Kikuchi H.
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct 20; 24(10):2411-7. PubMed ID: 2614179
    [Abstract] [Full Text] [Related]

  • 12. Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer.
    Mattson K, Holsti LR, Niiranen A, Kivisaari L, Iivanainen M, Sovijärvi A, Cantell K.
    J Biol Response Mod; 1985 Feb 20; 4(1):8-17. PubMed ID: 2984340
    [Abstract] [Full Text] [Related]

  • 13. [Antitumor efficacy of recombinant interferon-beta on human glioma].
    Miyao Y, Shimizu K, Okamoto Y, Matsui Y, Tsuda N, Yamada M, Tamura K, Mogami H.
    Gan To Kagaku Ryoho; 1987 Feb 20; 14(2):490-4. PubMed ID: 3813577
    [Abstract] [Full Text] [Related]

  • 14. [Combination therapy with IFN-beta, ACNU and radiation (IAR) in malignant brain tumors].
    Yoshida J, Wakabayashi T, Kato K, Enomoto H, Kito A, Kageyama N.
    Gan To Kagaku Ryoho; 1986 Mar 20; 13(3 Pt 1):520-4. PubMed ID: 3456740
    [Abstract] [Full Text] [Related]

  • 15. [rInterferon-alpha A (Ro 22-8181) therapy for patients with malignant brain tumors].
    Otsuka S, Yamashita J, Keyaki A, Handa H.
    Gan To Kagaku Ryoho; 1984 May 20; 11(5):1084-91. PubMed ID: 6326684
    [Abstract] [Full Text] [Related]

  • 16. [A study on the direct antitumoral effect of interferon-alpha on human glioma].
    Hamada H, Asakura T, Maeda Y, Yokoyama S, Niiro M.
    Gan To Kagaku Ryoho; 1986 Mar 20; 13(3 Pt 1):464-71. PubMed ID: 3954371
    [Abstract] [Full Text] [Related]

  • 17. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha.
    Wussow PV, Jakschies D, Freund M, Hehlmann R, Brockhaus F, Hochkeppel H, Horisberger M, Deicher H.
    Br J Haematol; 1991 Jun 20; 78(2):210-6. PubMed ID: 2064959
    [Abstract] [Full Text] [Related]

  • 18. Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study.
    Fetell MR, Housepian EM, Oster MW, Cote DN, Sisti MB, Marcus SG, Fisher PB.
    Cancer; 1990 Jan 01; 65(1):78-83. PubMed ID: 2293873
    [Abstract] [Full Text] [Related]

  • 19. Local administration of interferon for malignant brain tumors.
    Nakagawa Y, Hirakawa K, Ueda S, Suzuki K, Fukuma S, Kishida T, Imanishi J, Amagai T.
    Cancer Treat Rep; 1983 Sep 01; 67(9):833-5. PubMed ID: 6688376
    [Abstract] [Full Text] [Related]

  • 20. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation.
    Bartsch HH, Pfizenmaier K, Hanusch A, Scheurich P, Ucer U, Nagel GA.
    Int J Cancer; 1989 Feb 15; 43(2):235-40. PubMed ID: 2521842
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.